FDA Investigator: Kassa Ayalew
- Kassa Ayalew first started conducting FDA inspections in 2016, with the last inspection in 2019. Over that time, Kassa Ayalew has conducted 7 inspections at 7 companies across 7 sites.
Get Kassa Ayalew's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Novartis Pharmaceuticals, East Hanover | Dec 2018
Available Now - $199
Kassa Ayalew
Human Drug Form 483
FDA 483 PPD, Inc., Wilmington | 2019
Out-of-stock
Kassa Ayalew
Human Drug Form 483
FDA 483 Conrado Estol, M.D., Buenos Aires | 2018
Out-of-stock
Kassa Ayalew
Human Drug Form 483
FDA 483 Ajay Mehta, M.D., Nagpur 440010, Maharashtra | 2016
Out-of-stock
Kassa Ayalew
Human Drug Form 483
Co-Investigators (9)
- Rebecca T. Davis, FDA Investigator
- Cheryl A. Grandinetti, FDA Investigator
- Eileen J. Bannerman, FDA Investigator
- Peter R. Lenahan, FDA Investigator
- Sheri S. Oliver, FDA Investigator
- Tracy R. Ball, FDA Investigator
- Gene R. Gunn, FDA Investigator
- Tara K. Carmody, FDA Investigator
- Ethan P. Stegman, FDA Investigator